Bayer CropScience Limited (BSE: 506285) on Monday, May 26, 2025, announced its results for the financial year (FY) and quarter ended March 31, 2025.
In FY 2024-25, the Company’s Revenue from Operations increased to Rs 54,734 million, compared to Rs 51,062 million in the previous year. Profit Before Tax stood at Rs 7,074 million, compared to Rs 9,414 million in the previous year.
In Q4 of FY 2024-25, the Company registered Revenue from Operations of Rs 10,464 million, compared to Rs 7,923 million in the corresponding quarter of the previous year. Profit Before Tax for the quarter stood at Rs 1,679 million, compared to Rs 1,054 million in the corresponding quarter of the previous year.
Commenting on the quarterly results, Simon Wiebusch, Vice Chairman, Managing Director and CEO, BCSL said, “In Q4, our Revenue from Operations grew by 32 percent over the previous year, driven by strong performance in spring corn and by both strong performance and double-digit liquidation growth in the crop protection portfolio. The promotional investments made in the previous quarter generated significant returns. Quarter-on-quarter deviations reflect the realities of our agriculture. Our focus on liquidation-led channel management aligns with market realities and demonstrates our commitment to delivering continuous value.”
Speaking on the FY results, Vinit Jindal, Executive Director and Chief Financial Officer of BCSL, said, "Our Revenue from Operations grew by 7 percent for the full year, demonstrating our resilience amid challenges like unpredictable monsoons and competitive pressures. Despite strict cost management, higher input costs, provisions for doubtful receivables, and continued investments to expand Bayer’s reach among farmers, influenced our bottom line. Strategic investments drove operating costs."
He further added, "Moving forward, we will maintain focus on these initiatives and adapt our strategies to meet evolving market and stakeholder needs. The Board of Directors has recommended a final dividend payment of ₹35/- per equity share of ₹10/- each for the financial year ended March 31, 2025, subject to shareholders’ approval.”
